𝐏𝐫𝐒𝐦𝐚𝐫𝐲 π’πœπ₯𝐞𝐫𝐨𝐬𝐒𝐧𝐠 𝐂𝐑𝐨π₯𝐚𝐧𝐠𝐒𝐭𝐒𝐬 𝐌𝐚𝐫𝐀𝐞𝐭 π’π’π³πž 𝐚𝐧𝐝 π…π¨π«πžπœπšπ¬π­ 𝐛𝐲 2024-2032

π‘πžπšπ 𝐦𝐨𝐫𝐞: https://www.reportsandinsights.....com/report/primary-

Business

The global primary sclerosing cholangitis market was valued at US$ 162.3 Million in 2023 and is expected to register a CAGR of 7.8% over the forecast period and reach US$ 319.1 Mn in 2032.